The Five Business Plan Mistakes That Kill Deals Before They Start

Mistake 1 — The Hockey Stick With No Engine

Revenue projections that show moderate growth for two years then suddenly jump to something much higher. The plan doesn't explain what changes — no new product launch, no market expansion, no sales force investment. The growth just appears. Every buyer and investor has seen this. They will either discount it to a number they believe, or walk away because they don't trust the rest of the plan. If growth is going to accelerate, the plan needs to show specifically what drives it and what it costs. A consumer brand projecting next year's revenue at a rate consistent with its recent trajectory and sector benchmarks is credible on its face. The same brand projecting a sudden step-change in growth without a clear mechanism behind it signals either poor planning or dishonesty. Most buyers assume the latter.

Mistake 2 — Margins That Defy Gravity

EBITDA margins that expand every year without explanation. In consumer, beauty, and healthcare in particular, growth usually costs margin — you hire ahead of revenue, you invest in new markets, you spend on marketing. A plan that shows revenue growing and margins expanding simultaneously needs to explain exactly why, with specific cost assumptions. Otherwise the buyer assumes you're padding the numbers. A typical example: a beauty brand at a solid revenue base with healthy EBITDA margins projects significant revenue growth with margins expanding by several points simultaneously. When pressed, the answer is "efficiency." No specifics. No cost study. No operational plan. A buyer rejects that immediately. The reality in cases like this is usually that there are identifiable procurement savings and overhead reductions that can be documented — both defensible and quantifiable. Once those specifics are in the plan, the projection becomes credible. Without them, it's wishful thinking.

Mistake 3 — Customer Concentration Swept Under the Rug

The plan projects strong revenue growth but doesn't mention that a large share of current revenue comes from two clients. If either client churns, the growth story collapses. Buyers will find this in diligence. It's better to address it upfront — show the concentration, explain the retention dynamics, and model a downside scenario where the largest client reduces spending. Consider a healthcare distributor where two hospital networks represent a disproportionate share of sales. If the growth plan assumes both will maintain current volumes, a buyer will question that immediately. The plan only becomes credible once it models a scenario where one network reduces orders materially and shows the business still grows overall through new customer acquisition. A plan that models its own risks is harder to attack than one that ignores them.

Mistake 4 — Working Capital As An Afterthought

The plan focuses on revenue and EBITDA but ignores working capital dynamics. A fast-growing consumer brand that needs to fund inventory months before it collects revenue can have a beautiful P&L and a cash flow problem. PE in particular will scrutinize working capital because it directly impacts the cash available for debt service and distributions. If your plan doesn't model working capital explicitly, the buyer will — and their assumptions will be less generous than yours. Take a specialty cosmetics company projecting aggressive growth. The EBITDA looks strong. But if the model has no working capital line, the reality may be that the growth requires significant additional cash tied up in inventory and receivables. That's money that doesn't flow to debt service. Once you model payment terms realistically, extended procurement lead times, and inventory build cycles, the picture changes — and the growth targets often need adjusting.

Mistake 5 — The Plan You Can't Defend

The most dangerous mistake isn't in the numbers — it's not being able to explain them. Every assumption will be questioned. Why 12% revenue growth and not 8%? What's the basis for the 200bps margin improvement? How does the capex line reconcile with the growth plan? If you can't answer these questions clearly and consistently, the buyer loses confidence in the entire plan — not just the number they asked about. When a founder's answer changes three times across three questions about the same metric, the deal is lost right there. The buyer stops trusting that the plan is honest. Whether it was honest or not doesn't matter — trust is gone.

There is a variant of this that is even more destructive: the plan that is permanently in draft. I once had a CEO explain, with complete sincerity, that their business plan was a "permanent work in progress" — that they operated in fast-moving markets with limited visibility, that conditions shifted by country and by quarter, that short-term forecasts were inherently imprecise in their sector, and that this imprecision was offset by a structurally growing market. The environment was too volatile to commit to precise numbers, so the plan had to remain provisional — in practice, it was being revised nearly every week. And yet — and this is the part that reveals the real gap — the same CEO said in the same breath that this should not prevent a financial analyst or investor from analyzing the plan. He genuinely believed both things at once: the plan could not be pinned down, but it could still be evaluated. This sounds reasonable from the inside. From a buyer's perspective, these two statements are contradictory. There is no plan to diligence. A PE fund modelling a five-year return on your business needs numbers they can stress-test. If the plan is always changing, there is nothing to test. The buyer cannot underwrite what the seller cannot commit to. Every sector has volatility. Every plan has uncertainty. But a plan that acknowledges uncertainty through explicit scenarios and sensitivity analysis is fundable. A plan that uses uncertainty as a reason not to commit to numbers is not. There is a difference between "our base case is X, and here is how we perform if conditions deteriorate" and "we can't really forecast, so we revise constantly." The first is a plan. The second is not.

What To Do About It

The fix is simple but requires discipline: stress-test your own plan before someone else does. In any serious transaction, the buyer will commission a Quality of Earnings report — a forensic analysis conducted by an accounting firm that tests every material line in your P&L, restates your EBITDA, and flags every assumption that does not hold up. The QoE is the mechanism that turns each of the five mistakes above into a quantified valuation adjustment. You do not want to discover those adjustments for the first time in the buyer's QoE report. The alternative is to do your own version of this work first: extract every key assumption, test it against sector benchmarks, model downside scenarios, and make sure you can defend every number in a room with people who do this for a living. Some sellers commission a vendor due diligence — essentially a pre-sale QoE — to identify and fix problems before they become negotiating points. This is dramatically cheaper than discovering the issues during a live process.

Start with the drivers: revenue growth rates, gross margins, OpEx as a percentage of revenue, working capital requirements, and capex. For each one, write down the assumption. Then test it. What do similar-sized companies in your sector achieve? If your margins are higher, why specifically? If your growth is faster, what explains it? Don't assume you're just better. Be specific. A healthcare company with EBITDA margins above its sector average needs to explain why — whether it's proprietary technology, a high-touch sales model, or a unique distribution advantage. Once you understand why you're different, you can defend it.

Model three scenarios: base case, upside, and downside. The base case is your realistic view. The downside assumes one key assumption breaks — a major client leaves, a supplier raises prices, a new competitor enters. The upside assumes your best-case catalysts happen. A buyer won't be impressed by the upside. But they will be impressed if you've thought about the downside and can explain how the business survives it.

Finally, prepare to defend it. Write down the top 10 questions a skeptical buyer might ask, and write down your answer to each one. This isn't about rehearsing — it's about clarity. If you can't articulate why 12% growth makes sense, then maybe it doesn't. Better to discover that now than in a boardroom.

One important distinction: all of the above — the assumption testing, the scenario modelling, the EBITDA restatement — is the analytical foundation. Getting it right is necessary. It is not sufficient. The question that comes after "is my plan defensible?" is "how do I position this company to the right buyers, at the right time, in a process that maximises value?" That is a different kind of work entirely. It requires knowing which buyers are the right fit, how to frame the equity story, how to structure a process that creates competitive tension, and how to negotiate terms that reflect the actual value of what you built. This is where an independent M&A advisor — someone who has been on both sides of these processes — changes the outcome.

For more context on how buyers read financial plans, see our essay on what your company is worth. And to understand how adjustments flow through the process, read our guide to adjusted EBITDA.